Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Khalid Islam is an entrepreneur and businessperson who founded 6 companies, among them: Gain Therapeutics, Inc., Sirius Healthcare Partners GmbH and BioAim LLC and who has been at the helm of 13 different companies. Currently, he is Chairman of Fennec Pharmaceuticals, Inc., Chairman at Minoryx Therapeutics SL, Chairman at Gain Therapeutics, Inc. (which he founded in 2017), Chairman for GT Gain Therapeutics SA (a subsidiary of Gain Therapeutics, Inc.), Managing Director at Life Sciences Management GmbH (which he founded in 2014) and Partner at Sirius Healthcare Partners GmbH (which he founded in 2009). Khalid Islam is also on the board of Processa Pharmaceuticals, Inc. and Elion Oncology, Inc. and Advisor at Kurma Biofund FCPR.

Dr. Islam previously was Chairman at Caerus Consulting AS, Chairman at Ki Consulting AG (he founded the company in 2010), Chairman of Arpida, Inc., Chairman of Pcovery ApS, Chairman for Adenium Biotech ApS, Chairman at Adenium AB, Chairman & Chief Executive Officer of Gentium Srl, President, Chief Executive Officer & Director at Arpida AG, Head-Biotechnology at Marion Merrell Dow (Europe) AG, Team Leader & Manager-Alliance at Hoechst Marion Roussel Group and Professor at the University of Milan.

Dr. Islam received an undergraduate degree from Chelsea College and a doctorate from Imperial College London.


Current positions of Khalid Islam 
NameTitle Since
Gain Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2017
Fennec Pharmaceuticals Inc.
(Biotechnology & Medical Research)
Chairman 2015
Processa Pharmaceuticals, Inc.
(Pharmaceuticals)
Director 2020
Life Sciences Management GmbH Managing Director 2014
Minoryx Therapeutics SL Chairman 2016
GT Gain Therapeutics SA Chairman -
Elion Oncology, Inc. Director -
Kurma Biofund FCPR Advisor -
Sirius Healthcare Partners GmbH Partner 2009


Holdings of Khalid Islam 
NameEquities%Valuation
Gain Therapeutics, Inc. (GANX)
(Biotechnology & Medical Research)
880,7847.42%6,870,115 USD
Processa Pharmaceuticals, Inc. (PCSA)
(Pharmaceuticals)
171,9121.10%1,120,866 USD
Fennec Pharmaceuticals Inc. (FENC)
(Biotechnology & Medical Research)
00.0000%0 USD


Khalid Islam: Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Khalid Islam : Connections